Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

Blood Cancer Journal, Published online: 30 October 2020; doi:10.1038/s41408-020-00377-0Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Source: Blood Cancer Journal - Category: Hematology Authors: Source Type: research